Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Those who took offering so far lost another 50% on top

<< Previous

Bullboard Posts

Next >>

Comment by AllonGreenon Nov 21, 2019 1:12pm

65 Views

Post# 30379031

RE:Those who took offering so far lost another 50% on top

Not if you exercised your rights, sold at $22 back down to your initial share count ;)

Then you'd have caught up on at least some of your losses......

<< Previous

Bullboard Posts

Next >>

The Market Online’s Weekly Gold Report – Nov. 6, 2024